Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for SeaStar Medical Holding (ICU) over the last 3 years, with Q2 2025 value amounting to -$246000.0.

  • SeaStar Medical Holding's Other Non Operating Income fell 11713.09% to -$246000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $133000.0, marking a year-over-year increase of 10070.8%. This contributed to the annual value of -$7.0 million for FY2024, which is 4189.82% up from last year.
  • Per SeaStar Medical Holding's latest filing, its Other Non Operating Income stood at -$246000.0 for Q2 2025, which was down 11713.09% from $53000.0 recorded in Q1 2025.
  • SeaStar Medical Holding's 5-year Other Non Operating Income high stood at $1.4 million for Q2 2024, and its period low was -$8.7 million during Q1 2024.
  • Moreover, its 3-year median value for Other Non Operating Income was -$134000.0 (2024), whereas its average is -$2.0 million.
  • The largest annual percentage gain for SeaStar Medical Holding's Other Non Operating Income in the last 5 years was 10533.33% (2024), contrasted with its biggest fall of 24779.32% (2024).
  • Over the past 3 years, SeaStar Medical Holding's Other Non Operating Income (Quarter) stood at -$6.5 million in 2023, then soared by 105.33% to $348000.0 in 2024, then crashed by 170.69% to -$246000.0 in 2025.
  • Its Other Non Operating Income stands at -$246000.0 for Q2 2025, versus $53000.0 for Q1 2025 and $348000.0 for Q4 2024.